H19 and ovarian cancer: We previously reported that metformin reduces the motility and invasiveness of both endometrial and ovarian cancer cells in part by decreasing the production of H19.5 H19 is a long noncoding RNA that is highly expressed during fetal development but strongly downregulated in most adult tissues.